Navigation Links
Alcon Commences Phase 2 Clinical Trial of NovaBay's NVC-422 for Viral Conjunctivitis
Date:7/5/2009

well as in contact lens care solutions. NovaBay has also entered into an agreement with Galderma S.A. to develop and commercialize Aganocides in acne, impetigo and other dermatological indications. NovaBay(R) and Aganocide(R) are trademarks of NovaBay Pharmaceuticals, Inc. For more information on NovaBay, visit: www.novabaypharma.com.

Forward-Looking Statements

The statements in this press release regarding NovaBay's and Alcon's expectations regarding the clinical trial and the potential efficacy of Aganocide(R) compounds are forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. The forward- looking statements reflect the views of the management of NovaBay and Alcon as of the date of this press release with respect to future events and are based on assumptions and subject to significant risks and uncertainties (many of which are outside of NovaBay's or Alcon's control), including the risk that FDA or other regulatory review may delay or prevent the development of Aganocide(R) compounds, and those detailed in the NovaBay's and Alcon's filings with the Securities and Exchange Commission. Given these uncertainties, you should not place undue reliance on these forward-looking statements. Except to the extent required under the federal securities laws and the rules and regulations promulgated by the Securities and Exchange Commission, we undertake no obligation to publicly update or revise any of these forward-looking statements, whether to reflect new information or future events or circumstances or otherwise.


'/>"/>
SOURCE NovaBay Pharmaceuticals, Inc.; Alcon, Inc.
Copyright©2009 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4

Related medicine technology :

1. ORBIS and Alcon Call Attention to the Aging Eye
2. Amicus Therapeutics Commences Phase 3 Trial Evaluating Amigal(TM) for the Treatment of Fabry Disease
3. Rigel Commences Phase 2 Trial of R788 in Peripheral T-Cell Lymphomas
4. Novexels NXL104/ceftazidime Combination Commences Second Phase II Clinical Trial in Hospital Patients With Complicated Intra-Abdominal Infections (cIAIs)
5. VentiRx Pharmaceuticals Commences Phase I Clinical Trial of VTX-2337, a Novel TLR8 Agonist for the Treatment of Oncology
6. Novexels NXL104/ceftazidime Combination Commences Phase II Clinical Trial in Hospital Patients With Complicated Urinary Tract Infections
7. Oramed Pharmaceuticals Commences Phase 2A Trials of its Oral Insulin Capsule on Type 1 Diabetics
8. Logical Therapeutics Inc. Commences Double-Blind, Randomized Study of Their Lead Program, LT-NS001
9. Cytopia Commences Second Phase II Study in Brain Cancer
10. Anesiva Commences Phase 2 Trial of Adlea(TM) in Arthroscopic Shoulder Surgery
11. Pharmasset Commences Dosing R7128 Cohorts 3 and 4 for the Treatment of Chronic Hepatitis C
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/19/2013)... /PRNewswire-iReach/ -- Today leading web researchers Change Sciences Group ... web sites for usability, engagement, and conversion. The rankings ... which compares how people experience sites with competitors and ... The top three performers are easier to use, more ... performers have usability problems, lack aspects of design that ...
(Date:6/19/2013)... MOUNTAIN VIEW, Calif. , June 19, 2013 ... a leading provider of medication and supply management ... announced that it was named the number one ... Medical Equipment & Infrastructure Report. KLAS, a leading ... all pharmacy automation equipment vendors in its annual ...
(Date:6/19/2013)... 2013  It may seem like an odd pairing: an ... But these were two of the most talked about topics ... Meeting & Expo that just convened in San ... by some of the top internal medicine experts in the ... research that can not only save lives, but help people ...
Breaking Medicine Technology:Sunovion tops new Change Sciences User Experience Rankings for Pharmaceutical Industry while McNeil-PPC ranks worst overall 2Omnicell Named Top Vendor in 2013 KLAS Pharmacy Automation Equipment Rankings 2Omnicell Named Top Vendor in 2013 KLAS Pharmacy Automation Equipment Rankings 3Omnicell Named Top Vendor in 2013 KLAS Pharmacy Automation Equipment Rankings 4"Miracle" Breast Cancer Drug and "Youth Hormone" Pill Steal Show at Prestigious Endocrine Society Conference 2"Miracle" Breast Cancer Drug and "Youth Hormone" Pill Steal Show at Prestigious Endocrine Society Conference 3"Miracle" Breast Cancer Drug and "Youth Hormone" Pill Steal Show at Prestigious Endocrine Society Conference 4
(Date:6/19/2013)... 2013 HASCO Medical, Inc. (OTCBB: ... intent to purchase privately held Auto Mobility Sales, ... wheelchair accessible vehicle sales, service and rentals in ... Inc compliments and expands HASCO's strategy of becoming ... dealers . The acquisition is subject to customary ...
(Date:6/19/2013)... Nashville, TN (PRWEB) June 19, 2013 ... the appointment of Dr. John Baxter to Vice President, ... currently serves as Director, Mental Health Services for CCA. ... "It is an honor and great privilege to lead ... offers the unique opportunity to serve society and our ...
(Date:6/19/2013)... (PRWEB) June 19, 2013 Brain not ... DC, MS, explains why such seemingly minor brain problems ... concussions are vital red flags. They indicate the brain ... multiple sclerosis (MS), Alzheimer’s, Parkinson’s, stroke, and other neurological ... in June 2013 by Elephant Press is now available ...
(Date:6/19/2013)... 19, 2013 Strict rules for ... 2013, Orriant is launching a new tool to ... compliance with regulations. New HHS regulations will ... incentives if their employer offers outcome-based, health-contingent, compliant ... compliant with these standards for nearly a decade. ...
(Date:6/19/2013)... Today, Zane Benefits, Inc. published new ... Zane Benefits, which provides comprehensive and flexible alternatives to ... defined contribution and health reimbursement arrangement ... part of the Affordable Care Act (ACA), health insurance ... through new state health insurance exchanges. , Most importantly, ...
Breaking Medicine News(10 mins):Health News:HASCO Medical, Inc. to Acquire Auto Mobility Sales, Inc. 2Health News:CCA Names Dr. John Baxter Vice President, Health Services 2Health News:Brain Not Working? Minor Symptoms Now Could Mean MS, Alzheimer's, or Parkinson's Later 2Health News:Brain Not Working? Minor Symptoms Now Could Mean MS, Alzheimer's, or Parkinson's Later 3Health News:New Tool to Increase Participation Rates for Corporate Wellness Programs in July 2013 Will Help Maintain Compliance with Federal Regulations 2Health News:New Tool to Increase Participation Rates for Corporate Wellness Programs in July 2013 Will Help Maintain Compliance with Federal Regulations 3Health News:Zane Benefits Publishes New Information on the Wisconsin Health Insurance Exchange 2Health News:Zane Benefits Publishes New Information on the Wisconsin Health Insurance Exchange 3
... disease seems to have struck the honeybee population across the ... have been affected by this weird ailment. This has adversely ... ,Bee keepers have reported a loss of at least half ... mite had devastated many beehives and their populations in US. ...
... new type of nanoparticle that could be used in ... as well as for medical diagnosis. The research appears ... ,Nanoparticles, according to Ian Kennedy, professor in ... author of a paper describing the work, are microscopic ...
... Trichomonas vaginalis significantly increases a woman’s risk of becoming ... the March 1st edition of The Journal of Infectious ... established that several sexually transmitted infections increase the risk ... 173 million cases of Trichomonas vaginalis per year worldwide, ...
... have found a set of "master switches" that keep ... the switches' code may one day enable scientists to ... cancer and other bone marrow disorders. ,The ... level, but farther down the protein production line in ...
... the active ingredient in marijuana but produced naturally in ... offer a novel target for treating Parkinson's disease. ... the latest issue of the journal Nature, show how ... in the brain to transmit signals - form part ...
... accurately identify colorectal cancer patients with a specific type ... patient has an inherited// form of the disease or ... ,Some people with colorectal cancer have defects in ... these mutations by looking for a gene marker called ...
Cached Medicine News:Health News:UC Davis Creates New Nanoparticles 2Health News:Vaginalis Increases the Risk of Becoming Infected With HIV 2Health News:Vaginalis Increases the Risk of Becoming Infected With HIV 3Health News:Master Switches Found for Adult Blood Stem Cells 2Health News:Natural Brain Substance Linked to Parkinson's Symptoms 2
... Direct has been selling replacement ... 1996, and we are extremely ... guarantee. Check out our catalog ... our discount light bulbs specials. ...
... been selling replacement bulbs on ... we are extremely proud of ... out our catalog of replacement ... light bulbs specials. ,Check ...
... With the Symphony family of Pacemakers, ... the market. Symphony, lighter than a passport, ... follow-up, using new technologies, and delivering powerful ... also indicated for dual-chamber and atrial tracking ...
With the Symphony family of Pacemakers, Ela presents the most advanced technology on the market. Symphony, lighter than a passport, will take your patients further, offering fast follow-up, using new...
Medicine Products: